Neoadjuvant Anti-PD-1 Active in Multiple Tumors (CME/CE)

(MedPage Today) -- Major responses in pilot study for NSCLC, melanoma, bladder cancers

Source: MedPage Today Dermatology - April 18, 2018 Category: Dermatology Source Type: news